About this item:

256 Views | 386 Downloads

Author Notes:

Correspondence to: Tamil Kendall, PhD, Maternal Health Task Force, Women and Health Initiative, Department of Global Health and Population, Harvard School of Public Health, Boston, MA 02115 (e-mail: tkendall@hsph.harvard.edu).

Florence Anam, Lucy Gati and Jennifer Gatsi-Mallet provided comments on a draft manuscript.

The findings and conclusions in this article are those of the authors and do not necessarily represent the official positions of the United States Government, the CDC, Office of the Global AIDS Coordinator, USAID, the Canadian Institutes of Health Research, the Pierre Elliott Trudeau Foundation, or the Bill & Melinda Gates Foundation.

The authors have no conflicts of interest to disclose.

Subjects:

Research Funding:

Supported by the Maternal Health Task Force, which is supported through grant #01065000621 from the Bill & Melinda Gates Foundation, and the US Centers for Disease Control and Prevention.

Postdoctoral fellowship of T.K. is supported by the Canadian Institutes of Health Research and the Pierre Elliott Trudeau Foundation.

Keywords:

  • Science & Technology
  • Life Sciences & Biomedicine
  • Immunology
  • Infectious Diseases
  • HIV
  • maternal health
  • maternal mortality
  • research priorities
  • women's health
  • pregnancy
  • INTIMATE-PARTNER VIOLENCE
  • TO-CHILD TRANSMISSION
  • ACTIVE ANTIRETROVIRAL THERAPY
  • CLUSTER-RANDOMIZED-TRIAL
  • INFECTED PREGNANT-WOMEN
  • SOUTH-AFRICA
  • CONTRACEPTIVE UPTAKE
  • INCREASED RISK
  • CARE
  • HEALTH

Eliminating Preventable HIV-Related Maternal Mortality in Sub-Saharan Africa: What Do We Need to Know?

Show all authors Show less authors

Tools:

Journal Title:

Journal of Acquired Immune Deficiency Syndromes

Volume:

Volume 67

Publisher:

, Pages S250-S258

Type of Work:

Article | Final Publisher PDF

Abstract:

Introduction: HIV makes a significant contribution to maternal mortality, and women living in sub-Saharan Africa are most affected. International commitments to eliminate preventable maternal mortality and reduce HIV-related deaths among pregnant and postpartum women by 50% will not be achieved without a better understanding of the links between HIV and poor maternal health outcomes and improved health services for the care of women living with HIV (WLWH) during pregnancy, childbirth, and postpartum.Methods: This article summarizes priorities for research and evaluation identified through consultation with 30 international researchers and policymakers with experience in maternal health and HIV in sub-Saharan Africa and a review of the published literature.Results: Priorities for improving the evidence about effective interventions to reduce maternal mortality and improve maternal health among WLWH include better quality data about causes of maternal death among WLWH, enhanced and harmonized program monitoring, and research and evaluation that contributes to improving: (1) clinical management of pregnant and postpartum WLWH, including assessment of the impact of expanded antiretroviral therapy on maternal mortality and morbidity, (2) integrated service delivery models, and (3) interventions to create an enabling social environment for women to begin and remain in care.Conclusions: As the global community evaluates progress and prepares for new maternal mortality and HIV targets, addressing the needs of WLWH must be a priority now and after 2015. Research and evaluation on maternal health and HIV can increase collaboration on these 2 global priorities, strengthen political constituencies and communities of practice, and accelerate progress toward achievement of goals in both areas.

Copyright information:

© 2014 by Lippincott Williams & Wilkins

This is an Open Access work distributed under the terms of the Creative Commons Attribution-NonCommerical-NoDerivs 3.0 Unported License (http://creativecommons.org/licenses/by-nc-nd/3.0/).

Creative Commons License

Export to EndNote